- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Merck’s V114 induces immune response in pneumococcal disease trials

3D image of a group of Gram-positive Streptococcus pneumoniae bacteria. Credit: CDC on Unsplash.